When would you consider use of emapalumab for HLH/MAS?
Community PollStarted
What therapies do you prefer for first line treatment of HLH/MAS?
24 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Rheumatology · University of Alabama Birmingham
Answered on
The FDA has approved emapalumab for familial HLH. For secondary HLH/MAS, I typically begin with anakinra (100 mg q 6 hrs for those 40 kg or more). If this is not enough and if CXCL9 (I send on day one to have the data available) is notably elevated, then consider adding emapalumab. Alternatively, a ...
Join for free or sign in to see the full answer